Results 211 to 220 of about 19,656,854 (402)

Integrating Occupational Health and Safety into Enterprise Risk Management: a structural evaluation. [PDF]

Front Public Health
Kılıç Y, Vayvay Ö.
europepmc   +1 more source

Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong, Shasha Yu, Jing Zhang, Yu Zu, Yujing Zhang, Jing Lv, Xuyang Cao, Xuedan Feng   +7 more
wiley   +1 more source

Study of risk management for orthodontists' practice in Taiwan. [PDF]

J Dent Sci
Wang SH, Hsin-Chung Cheng J, Huang KC, De-Shing Chen D.   +3 more
europepmc   +1 more source

Background risk information to assist in risk management decision making

, 1992
J.S. Hammonds, F.O. Hoffman, R.K. White, David B. Miller   +3 more
openalex   +1 more source

Impact of litigation on senior clinicians: implications for risk management. [PDF]

, 1997
Pippa Bark, Charles Vincent, Laura Olivieri, Angela Jones   +3 more
openalex   +1 more source

Risk management

Journal of British Surgery, 2001
openaire   +2 more sources

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Lumen-Apposing Metal Stent Bleeding Risk: Management of Splenic Artery Erosion. [PDF]

ACG Case Rep J
Côrte-Real F, Rego AC, Silva AR, Amaral N, Nunes N, Pereira JR, Duarte AMA.   +6 more
europepmc   +1 more source

Non-Parametric Risk Management and Implied Risk Aversion [PDF]

, 1998
Yacine Aït‐Sahalia, Andrew W. Lo
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source